Bio-Techne Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.6% | +11.3% | +0.9% | -5.4% | +2.6% | +6.4% | +0.2% | -9.6% | +3.3% | +5.3% | +3.1% | – | |
| – | +4.7% | +2.9% | +4.0% | +3.6% | -3.1% | -1.5% | +16.3% | -16.7% | +6.3% | -1.4% | +6.5% | – | |
| – | -4.6% | +15.9% | -0.6% | -10.0% | +5.9% | +10.7% | -7.3% | -5.4% | +1.7% | +8.9% | +1.5% | – | |
| – | -4.5% | +12.4% | -6.9% | -0.5% | +4.8% | -1.7% | +5.9% | -6.9% | -4.6% | +1.4% | +2.1% | – | |
| – | +9.8% | -3.3% | -42.8% | +86.2% | +1.9% | +24.6% | -84.7% | +400.6% | -2.2% | -3.8% | +3.5% | – | |
| – | +7.2% | -0.7% | +14.5% | -9.2% | +2.4% | +20.1% | +26.6% | -36.9% | -2.6% | -2.9% | +3.3% | – | |
| – | -32.0% | +76.3% | -31.6% | -12.7% | +18.6% | -18.4% | -161.6% | – | +14.3% | +38.6% | -1.6% | – | |
| – | -11.5% | -7.5% | -37.4% | -13.3% | -1.3% | -6.6% | +8.5% | +34.7% | -26.0% | +48.4% | -9.3% | – | |
| – | -32.6% | +83.0% | -31.8% | -3.6% | +6.7% | -10.7% | -159.7% | – | +5.8% | +40.3% | -0.8% | – | |
| – | – | +103.1% | -91.1% | +512.4% | +21.5% | +96.4% | -133.0% | – | +30.3% | +57.9% | -20.4% | – | |
| – | -46.1% | +78.6% | -17.3% | -17.2% | +3.8% | -35.3% | -178.3% | – | -0.5% | +34.3% | +7.0% | – | |
| – | -21.1% | +41.0% | -21.8% | -2.4% | +2.3% | -5.9% | -90.5% | +1,070.5% | +3.2% | +27.0% | -6.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.